Eprontia 25 mg/mL oral solution Images
Generic Name: topiramate
This medication has been identified as Eprontia 25 mg/mL oral solution and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images of medication
Eprontia
- Generic Name
- topiramate
- Strength
- 25 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Azurity Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 52652-9001
See also:
More about Eprontia (topiramate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Topamax, Trokendi XR, Qudexy XR, Topiragen
Professional resources
Other brands
Topamax, Trokendi XR, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.